(Q28190165)
Statements
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease (English)
0 references
9 December 2003
0 references
61
0 references
11 Suppl 6
0 references
S97-100
0 references